6Beauchamp NJ, Barker PB, Wang PY, et al. Imaging of acute cerebral ischemia. Radiology, 1999, 212(2): 307-324.
7Albers GW. Expanding the windows for thrombolytic therapyin Acute Stroke. The potential role of acute MRI for patient selection. Stroke,1999, 30(10) :2230 - 2237.
8Manelfe C, Larrue V, yon Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients with tissue plasminogen activator. Stroke, 1999, 30(4):769-772.
9Knight RA, Barker PB, Fagan SC, et al. Prediction of impending hemorthagic transformation in ischemic stroke using MRI in rats. Stroke,1998, 29(1):144- 151.
10Simone Wagner, Pamela Kalb, Egon Werle, et al. Poster presentations: Laminin levels in acute stroke patients may serve as a new marker for therapeutic decisions. Stroke, 2000, 31(1)327
7HunterGJ, HambergLM, PonzoJA, et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three dimensional functional CT: early clinical results [ J ]. AJN R, 1998:19,29,37.
8FlackeS,UrbachH,KellerE,et al. Middle cerebralartery(MCA)susceptibility sign at susceptibility based perfusion MRimaging:clinical importance and comparison with hyperdense MCA sign at CT [ J ].Radiology ,2000,215 ( 2 ) :476 - 82.
